Global Human Growth Hormone Market 2024-2028
Human Growth Hormone Market 2024-2028
The human growth hormone market is forecasted to grow by USD 949.1 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the human growth hormone market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by development of long-acting and needle-free deliveries to improve adherence, fda approval of human growth hormone replacement therapy for new indications, and strong pipeline of human growth hormones.
Technavio's human growth hormone market is segmented as below:
By Application
- Growth hormone deficiency
- ISS
- Turner syndrome
- PWS
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing incidence of growth disorders as one of the prime reasons driving the human growth hormone market growth during the next few years. Also, no impact of biosimilar entry into market and advanced technologies will lead to sizable demand in the market.
The report on the human growth hormone market covers the following areas:
- Human growth hormone market sizing
- Human growth hormone market forecast
- Human growth hormone market industry analysis
The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human growth hormone market vendors that include Abbott Laboratories, Aeterna Zentaris Inc., Anhui Anke Biotechnology Group Co. Ltd., Ascendis Pharma AS, F. Hoffmann La Roche Ltd., Ferring BV, Ipsen Pharma, LG Chem Ltd., Merck and Co. Inc., Novo Nordisk AS, Pfizer Inc., Sandoz Group AG, Teva Pharmaceutical Industries Ltd., Xeris Biopharma Holdings Inc., and Zhongshan Sinobioway Hygene Biomedicine Co. Ltd.. Also, the human growth hormone market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The comapniespresents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.